to the overall objectives as articulated. (6) Identifying the current agency of the Federal Government with the lead for pandemic preparedness and response. (7) Evaluating the integration of the pandemic planning into the National Preparedness System and other preparedness activities throughout the Federal Government. (8) Evaluating the performance of the Federal, State, and local governments in preparing for and responding to the COVID–19 declared emergency within the context of the National Preparedness System. (9) Assessing of the assignment of roles and responsibilities among Federal, State, and local governments in preparing for, responding to and recovering from the COVID–19 pandemic. (10) Evaluating of the performance of an all-hazard preparedness and response system in meeting the challenges of the COVID–19 emergency and whether actions should be taken to adapt preparedness and response to unique circumstances related to pandemics. (11) Evaluating whether the identification of lead person or agency for pandemic preparedness is clear and effective and whether the lead for pandemic preparedness and response requires consolidation or should be reassigned to an alternative agency. (12) Examining ways to improve integration and coordination of preparedness and responses to pandemics at all levels of government, Federal, State, and local. (13) Evaluating the resilience of production responses to the COVID–19 crisis particularly those related medicines, medical equipment, protective equipment and other medical supplies and the role of the Federal and other governments in responding to supply chain needs for pandemics. (14) Identifying and evaluating the degree of reliance of the United States on vulnerable supply chains for medicines, medical equipment, protective equipment and other medical supplies necessary to prepare for and respond to a pandemic and all reasonable alternatives for mitigating such vulnerabilities in future pandemics. (15) Evaluating the contribution of the Defense Production Act in the